Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -127,300 | -84,800 | -62,700 | -26,000 | -263,300 |
| Depreciation Amortization | 117,800 | 60,000 | 43,600 | 15,700 | 61,900 |
| Income taxes - deferred | -2,800 | -3,000 | -1,600 | N/A | -4,000 |
| Accounts receivable | -8,700 | -12,700 | -4,500 | -3,900 | -12,500 |
| Accounts payable and accrued liabilities | 4,700 | 5,800 | 9,400 | 6,100 | -3,700 |
| Other Working Capital | -54,400 | -30,200 | -22,900 | -20,600 | 27,000 |
| Other Operating Activity | 62,000 | 49,600 | 22,700 | 10,100 | 83,700 |
| Operating Cash Flow | $-8,700 | $-15,300 | $-16,000 | $-18,600 | $-110,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,000 | -6,600 | -11,900 | -6,700 | -63,200 |
| Net Acquisitions | 8,800 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 9,000 | 9,000 | 4,000 | 1,500 | 105,200 |
| Purchase Sale Intangibles | -10,700 | -8,400 | -5,600 | -1,900 | -10,100 |
| Other Investing Activity | -10,700 | -8,400 | -5,600 | -1,900 | -10,100 |
| Investing Cash Flow | $-11,900 | $-6,000 | $-13,500 | $-7,100 | $31,900 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 120,000 | 100,000 | 80,000 | 60,000 | 80,000 |
| Debt Repayment | -119,500 | -100,300 | -80,200 | -60,100 | -40,000 |
| Common Stock Issued | 5,900 | 3,000 | 3,000 | N/A | 123,600 |
| Other Financing Activity | -13,800 | -12,200 | -9,200 | -8,700 | -10,700 |
| Financing Cash Flow | $-7,400 | $-9,500 | $-6,400 | $-8,800 | $152,900 |
| Exchange Rate Effect | -1,000 | -300 | -1,500 | -800 | 600 |
| Beginning Cash Position | 140,900 | 140,900 | 140,900 | 140,900 | 66,400 |
| End Cash Position | 111,900 | 109,800 | 101,200 | 105,600 | 140,900 |
| Net Cash Flow | $-29,000 | $-31,100 | $-39,700 | $-35,300 | $74,500 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,700 | -15,300 | -16,000 | -18,600 | -110,900 |
| Capital Expenditure | -19,000 | -15,400 | -11,900 | -6,700 | -63,200 |
| Free Cash Flow | -27,700 | -30,700 | -27,900 | -25,300 | -174,100 |